These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4841712)

  • 1. Letter: Daunomycin (NSC-82151) and adriamycin (NSC-123127): a hypothesis concerning antitumor activity and cardiotoxicity.
    Adamson RH
    Cancer Chemother Rep; 1974; 58(3):293-4. PubMed ID: 4841712
    [No Abstract]   [Full Text] [Related]  

  • 2. Another hypothesis concerning the antitumor activity and cardiotoxicity of daunorubicin (NSC-82151) and adriamycin (NSC-123127).
    Wheeler DM
    Cancer Chemother Rep; 1975; 59(2 Pt 1):258-9. PubMed ID: 1149002
    [No Abstract]   [Full Text] [Related]  

  • 3. The cardiotoxicity of adriamycin and daunomycin in children.
    Gilladoga AC; Manuel C; Tan CT; Wollner N; Sternberg SS; Murphy ML
    Cancer; 1976 Feb; 37(2 Suppl):1070-8. PubMed ID: 1253124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of antitumor effectiveness of ICRF-159 (NSC-129943) against early L1210 leukemia by combination with cis-diamminedichloroplatinum (NSC-119875) or daunomycin (NSC-82151).
    Woodman RJ
    Cancer Chemother Rep 2; 1974 Mar; 4(1):45-52. PubMed ID: 4826499
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cardiotoxicity of anthracycline cytostatic agents--a proposal for routine monitoring and supportive therapy].
    Svojgrová M; Slechtová J; Hůla J
    Vnitr Lek; 1991 Feb; 37(2):151-9. PubMed ID: 2021075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: Adriamycin and the heart.
    Lancet; 1974 Jun; 1(7870):1325. PubMed ID: 4134302
    [No Abstract]   [Full Text] [Related]  

  • 7. Toxicologic screening of daunorubicin (NSC-82151), adriamycin (NSC-123127), and their derivatives in rats.
    Zbinden G; Brändle E
    Cancer Chemother Rep; 1975; 59(4):707-15. PubMed ID: 1175165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the reported lack of effectiveness of daunomycin (NSC-82151) and adriamycin (NSC-123127) on solid tumors.
    Lenaz L; Di Marco A
    Cancer Chemother Rep; 1972 Aug; 56(4):431-2. PubMed ID: 5081585
    [No Abstract]   [Full Text] [Related]  

  • 9. Daunomycin- and adriamycin-N-(2-hydroxypropyl)methacrylamide copolymer conjugates; toxicity reduction by improved drug-delivery.
    Seymour LW; Duncan R; Kopecková P; Kopecek J
    Cancer Treat Rev; 1987 Dec; 14(3-4):319-27. PubMed ID: 3326668
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of daunorubicin (NSC-83142) with adriamycin (NSC-123127) in the treatment of late-stage childhood solid tumors.
    Evans AE; Baehner RL; Chard RL; Leikin SL; Pang EM; Pierce M
    Cancer Chemother Rep; 1974; 58(5 Pt 1):671-6. PubMed ID: 4371948
    [No Abstract]   [Full Text] [Related]  

  • 11. Activity of anthracyclines against an adriamycin (NSC-123127)-resistant subline of P388 leukemia with special emphasis on cinerubin A (NSC-18334).
    Johnson RK; Ovejera AA; Goldin A
    Cancer Treat Rep; 1976 Jan; 60(1):99-102. PubMed ID: 826316
    [No Abstract]   [Full Text] [Related]  

  • 12. Time- and dose-dependent changes in ejection fraction after anthracycline therapy.
    Narahara KA; Singer JW; Ritchie JL; Williams DL; Hamilton GW; Kennedy JW
    J Cardiovasc Pharmacol; 1979; 1(4):395-401. PubMed ID: 94617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter: DNA complexes of daunorubicin (NSC-8215) and adriamycin (NSC-123127).
    Trouet A; de Duve C
    Cancer Chemother Rep; 1975; 59(2 Pt 1):260. PubMed ID: 1149004
    [No Abstract]   [Full Text] [Related]  

  • 14. The cardiotoxicity of anticancer agents.
    Von Hoff DD; Rozencweig M; Piccart M
    Semin Oncol; 1982 Mar; 9(1):23-33. PubMed ID: 7071608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter: Contact dermatitis associated with adriamycin (NSC-123127) and daunorubicin (NSC-82151).
    Reich SD; Bachur NR
    Cancer Chemother Rep; 1975; 59(4):677-8. PubMed ID: 1175160
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cardiotoxicity of cytostatics in long-term therapy].
    Bühner R
    Dtsch Med Wochenschr; 1978 Aug; 103(33):1311-2. PubMed ID: 98313
    [No Abstract]   [Full Text] [Related]  

  • 17. Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats.
    Mettler FP; Young DM; Ward JM
    Cancer Res; 1977 Aug; 37(8 Pt 1):2705-13. PubMed ID: 872096
    [No Abstract]   [Full Text] [Related]  

  • 18. [The heart and drug poisoning, excluding cardiologic treatments].
    Nicolas G; Bouhour JB; Godin JF; Rozo L; Chareyre M
    Arch Mal Coeur Vaiss; 1978 Apr; 71(4):471-6. PubMed ID: 96765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adriamycin and its analogs].
    Arcamone F
    Tumori; 1984 Apr; 70(2):113-9. PubMed ID: 6587651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA complexing antibiotics: daunomycin, adriamycin and their derivatives.
    Marco A; Arcamone F
    Arzneimittelforschung; 1975 Mar; 25(3):368-74. PubMed ID: 1174034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.